Summit Therapeutics Plc reported raising $25 Million in an initial SEC Form D filing, from an offering of $25 Million
Amount Raised
$25 Million
Round Type
Venture
MiamiBiotechnologyHealth CareTherapeuticsBiopharmaWho else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Summit Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- GENOCEA BIOSCIENCES, INC. raised $12M on February 27, 2019.
- vTv Therapeutics Inc. raised $1.5M (Seed) on January 4, 2019.
- HOOKIPA Pharma raised $37M on February 27, 2019.
- Neurogene raised $38M on February 25, 2019.
- Sagimet Biosciences Inc. raised $35M on February 25, 2019.
- Aldeyra Therapeutics raised $10M on February 11, 2019.
Who to call at Summit Therapeutics, and when
A new round usually means Summit Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Summit Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Summit Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Summit Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Summit Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Summit Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.